Cell Signaling Technology

RasGRP3 (C33A3) Rabbit Monoclonal Antibody

#3334 · $158

100
Citing papers
12k
Combined citations
Supplier page Find this product

Research areas

Cytokine Signaling Pathways and Interactions9Hippo pathway signaling and YAP/TAZ8Cancer, Hypoxia, and Metabolism7Lung Cancer Treatments and Mutations6HER2/EGFR in Cancer Research6Neuroscience and Neuropharmacology Research5Chronic Myeloid Leukemia Treatments4Nerve injury and regeneration4

Papers citing this product

1
Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis
Genes & Development·2003·681 cit.·DOI
2
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
Nature Communications·2019·360 cit.·DOI
3
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group
Blood·2009·345 cit.·DOI
4
GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions
Journal of Clinical Investigation·2019·341 cit.·DOI
5
Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation
Genes & Development·2013·339 cit.·DOI
6
Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics
Nature Communications·2021·297 cit.·DOI
7
Oral Consumption of Green Tea Polyphenols Inhibits Insulin-Like Growth Factor-I–Induced Signaling in an Autochthonous Mouse Model of Prostate Cancer
Cancer Research·2004·295 cit.·DOI
8
Adaptable haemodynamic endothelial cells for organogenesis and tumorigenesis
Nature·2020·253 cit.·DOI
9
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
Nature Communications·2024·237 cit.·DOI
10
Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective <i>BRAF</i> Inhibition
Journal of Clinical Oncology·2012·225 cit.·DOI